Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 7/20 | 0.60 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.56 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.56 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 3/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28226601 | 0.95 | ADRB2 (0.61) | LPAR1ADRB2ADRB1ADRB3TDP1 | |
| SCHEMBL3185725 | 0.89 | TDP1 (0.68) | ADRB2ADRB1ADRB3MAPTTDP1 | |
| SCHEMBL31657295 | 0.85 | ADRB2 (0.57) | LPAR1ADRB2ADRB1ADRB3TDP1 | |
| SCHEMBL11043709 | 0.84 | ALDH1A1 (0.53) | LPAR1ADRB2ADRB1ADRB3TDP1 | |
| SCHEMBL7970656 | 0.84 | LPAR1 (0.47) | LPAR1ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL7971409 | 0.84 | LPAR1 (0.47) | LPAR1ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL7968764 | 0.84 | LPAR1 (0.47) | LPAR1ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL6328999 | 0.82 | ALOX5 (0.69) | LPAR1MAPTRXFP1TDP1ALOX5 | |
| SCHEMBL19024934 | 0.82 | ADRB2 (0.57) | LPAR1ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL27770588 | 0.82 | ADRB2 (0.57) | LPAR1ADRB2ADRB1ADRB3TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210189289-A1 | Functionalized Branched Alcohols As Non-Ionic Sugar Surfactants | EXXONMOBIL RES & ENG CO (US) | 2021-06-24 | — | — | US | disclosed |
| US-20210188749-A1 | Surfactant Performance Through Carbon Chain Extension And Lower Branching | EXXONMOBIL RES & ENG CO (US) | 2021-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210188749-A1 | Surfactant Performance Through Carbon Chain Extension And Lower Branching | CCL11, SPTSSB, PAOX | LPAR1 1168/4885ADRB2 235/4885ADRB1 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.